Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle

This study is currently recruiting participants.

Verified by King Khaled Eye Specialist Hospital, June 2009

First Received: July 1, 2008 Last Updated: June 15, 2009 History of Changes

Sponsored by:	King Khaled Eye Specialist Hospital
Information provided by:	King Khaled Eye Specialist Hospital
ClinicalTrials.gov Identifier:	NCT00735657

Purpose

Periocular blockade with 12.5 mm needle is as effective as block with 25 mm needle for patients undergoing Pars Plana Vitrectomy.

Condition	Intervention
Retinal Disorders	Device: needle Procedure: Pars Plana Vitrectomy

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Investigator), Active Control, Parallel Assignment, Safety Study
Official Title:	Anesthesia for PPV Using Insulin Needle

Resource links provided by NLM:

MedlinePlus related topics: Anesthesia Retinal Disorders

Drug Information available for: Insulin Temazepam

U.S. FDA Resources

Further study details as provided by King Khaled Eye Specialist Hospital:

Primary Outcome Measures:

Efficacy of insulin needle. [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Estimated Enrollment:	120
Study Start Date:	August 2008
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Group 1: Active Comparator Control	Device: needle Peribulbar blockade with standard (25 mm) needle Procedure: Pars Plana Vitrectomy Peribulbar block
Group 2: Active Comparator Block with short needle	Device: needle Peribulbar blockade with short (12.5 mm) needle Procedure: Pars Plana Vitrectomy Peribulbar block

Detailed Description:

The author wants to see the effect of short needle in patients undergoing retinal surgery.

Eligibility

Ages Eligible for Study:	40 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adult patients undergoing pars plana vitrectomy under local anesthesia

Exclusion Criteria:

Patients allergic to local anesthetic solutions
With local sepsis
Serious impairment of coagulation
Orbital abnormalities
Unable to cooperate in maintaining a relatively motionless supine position
Who refused the anesthetic technique

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00735657

Contacts

Contact: Waleed Riad, MD,AB,SB

0096614821234 ext 3215

waleed_riad@yahoo.com

Locations

Saudi Arabia
King Khaled Eye Specialist hospital	Recruiting
Riyadh, Saudi Arabia, 11462
Contact: Waleed Riad 0096614821234 ext 3215 waleed_riad@yahoo.com
Principal Investigator: Waleed Riad, MD, AB,SB

Sponsors and Collaborators

King Khaled Eye Specialist Hospital

Investigators

Principal Investigator:

Waleed Riad, MD

KKESH

More Information

No publications provided

Responsible Party:	King Khaled Eye Specialist Hospital ( Waleed Riad MD )
Study ID Numbers:	Rp0822
Study First Received:	July 1, 2008
Last Updated:	June 15, 2009
ClinicalTrials.gov Identifier:	NCT00735657 History of Changes
Health Authority:	Saudi Arabia: Ministry of Health

Keywords provided by King Khaled Eye Specialist Hospital:

Efficiency
Pars
Plana
Vitrectomy

Study placed in the following topic categories:

Eye Diseases
Temazepam
Anesthetics
Insulin
Retinal Diseases

Additional relevant MeSH terms:

Eye Diseases
Retinal Diseases

ClinicalTrials.gov processed this record on September 04, 2009